These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 3139442)

  • 21. Praziquantel pharmacotherapy reduces systemic osteopontin levels and liver collagen content in murine schistosomiasis mansoni.
    Pereira TA; Vaz de Melo Trindade G; Trindade Santos E; Pereira FEL; Souza MM
    Int J Parasitol; 2021 May; 51(6):437-440. PubMed ID: 33493521
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Schistosoma mansoni: effect of dietary zinc supplement on egg granuloma in Swiss mice treated with praziqantel.
    Helmy MM; Mahmoud SS; Fahmy ZH
    Exp Parasitol; 2009 Aug; 122(4):310-7. PubMed ID: 19389399
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Propolis enhances the effectiveness of praziquantel in experimental schistosomiasis: biochemical and histopathological study.
    Mahmoud TY; Rizk SM; Maghraby AS; Shaheen AA
    Parasitol Res; 2014 Dec; 113(12):4513-23. PubMed ID: 25266217
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of acute schistosomiasis mansoni with praziquantel and an antifibrotic agent in mice. Maintenance of resistance to infection.
    Hassan SI; Ali I; Nessim NG; Amer NM; Abd el Kader el Khafif M; Ashour A; el Mohandes M
    Arzneimittelforschung; 2003; 53(6):440-4. PubMed ID: 12872615
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of praziquantel treatment on hepatic pathology of Schistosoma mansoni experimentally infected mice.
    Khalil HM; Bebars MA; el-Badawy NM; Abdallah HM; Khalil NM; el-Zayyat EA; el-Din Mohamed MS
    J Egypt Soc Parasitol; 1995 Apr; 25(1):269-77. PubMed ID: 7602169
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparative study on the anti-schistosomal and hepatoprotective effects of vinpocetine and isosorbide-5-mononitrate on Schistosoma mansoni-infected mice.
    Alhusseiny SM; El-Beshbishi SN; Hashim MMA; El-Nemr HEE; Handoussa AE
    Acta Trop; 2017 Dec; 176():114-125. PubMed ID: 28757393
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Remodeling of hepatic vascular changes after specific chemotherapy of schistosomal periportal fibrosis.
    Andrade ZA; Baptista AP; Santana TS
    Mem Inst Oswaldo Cruz; 2006 Sep; 101 Suppl 1():267-72. PubMed ID: 17308780
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antifibrotic and anthelminthic effect of casticin on Schistosoma mansoni-infected BALB/c mice.
    Lam HYP; Liang TR; Lan YC; Chang KC; Cheng PC; Peng SY
    J Microbiol Immunol Infect; 2022 Apr; 55(2):314-322. PubMed ID: 34167886
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Factors controlling the effect of praziquantel on liver fibrosis in Schistosoma mansoni-infected patients.
    Rahoud SA; Mergani A; Khamis AH; Saeed OK; Mohamed-Ali Q; Dessein AJ; Elwali NE
    FEMS Immunol Med Microbiol; 2010 Feb; 58(1):106-12. PubMed ID: 20030714
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Colchicine therapy for hepatic murine schistosomal fibrosis: image analysis and serological study.
    Badawy AA; el-Badrawy NM; Hassan MM; Ebeid FA
    Int J Exp Pathol; 1999 Feb; 80(1):25-34. PubMed ID: 10365084
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of anti-schistosomal treatment on schistosomal hepatic pathology: an experimental study in Syrian golden hamsters.
    Moustafa FE; Hamouda MM; el-Shazly AM; Sheha G; Hamid S; el-Naggar HM; Habib FS; Morsy TA
    J Egypt Soc Parasitol; 1996 Aug; 26(2):517-24. PubMed ID: 8754659
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Parasitological and histo-pathological studies on schistosomiasis mansoni infected mice and treated with praziquatel and/or oltipraz.
    Morsy GH
    J Egypt Soc Parasitol; 2009 Aug; 39(2):687-701. PubMed ID: 19795775
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The potent effect of silymarin combination with Praziquantel or mirazid for Schistosoma mansoni treatment in infected male swiss albino mice.
    El-Nagar DM; Al Olayan EM; Aloufi AS; Khatab AR
    Trop Biomed; 2021 Mar; 38(1):22-27. PubMed ID: 33797519
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effect of ginsenoside Rg3 on hepatic fibrosis in murine schistosomiasis japonica].
    Zeng J; Wang H; Jia XM; Li CY; Li F
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2011 Apr; 29(2):107-10. PubMed ID: 21826894
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Auranofin attenuates
    Atia AF; Abou-Hussien NM; Sweed DM; Sweed E; Abo-Khalil NA
    J Helminthol; 2023 Dec; 97():e95. PubMed ID: 38053397
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and tolerance of praziquantel in patients with Schistosoma mansoni infection and Symmers' fibrosis: a field study in the Sudan.
    Homeida MM; el Tom IA; Sulaiman SM; Daffalla AA; Bennett JL
    Am J Trop Med Hyg; 1988 May; 38(3):496-8. PubMed ID: 3152777
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The hepatoprotective activity of blue green algae in Schistosoma mansoni infected mice.
    Mohamed AH; Osman GY; Salem TA; Elmalawany AM
    Exp Parasitol; 2014 Oct; 145():7-13. PubMed ID: 25016189
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Telmisartan, an AT1 receptor blocker and a PPAR gamma activator, alleviates liver fibrosis induced experimentally by Schistosoma mansoni infection.
    Attia YM; Elalkamy EF; Hammam OA; Mahmoud SS; El-Khatib AS
    Parasit Vectors; 2013 Jul; 6():199. PubMed ID: 23829789
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Single-sex infection with female Schistosoma mansoni cercariae mitigates hepatic fibrosis after secondary infection.
    Koslowski N; Sombetzki M; Loebermann M; Engelmann R; Grabow N; Österreicher CH; Trauner M; Mueller-Hilke B; Reisinger EC
    PLoS Negl Trop Dis; 2017 May; 11(5):e0005595. PubMed ID: 28542175
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 24-nor-ursodeoxycholic acid ameliorates inflammatory response and liver fibrosis in a murine model of hepatic schistosomiasis.
    Sombetzki M; Fuchs CD; Fickert P; Österreicher CH; Mueller M; Claudel T; Loebermann M; Engelmann R; Langner C; Sahin E; Schwinge D; Guenther ND; Schramm C; Mueller-Hilke B; Reisinger EC; Trauner M
    J Hepatol; 2015 Apr; 62(4):871-8. PubMed ID: 25463533
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.